Home
Dashboard
Why Turin?
Curated content

Companies
Investors
More organizations

Job board
Transactions

Stats & Insights
Matching tool

Powered by

Comitato Torino Finanza
Camera di commercio di Torino
Compagnia di San Paolo
Fondazione Sviluppo e Crescita CRT
dealroom.co
Talent Garden
KiwiFarm

Contact
FAQ
Privacy

Companies
GenSight Biologics
Team
Team

GenSight Biologics

Develops innovative therapies for mitochondrial and neurodegenerative diseases.

Launch date

2012

Employees

Market cap

€39.8m

Enterprise valuation

€56m (Public information from Sep 2024)

Share price

€0.395 SIGHT.PA

Company register number 751164757

Paris Île-de-France (HQ)

http://www.gensight-biologics.com/

https://twitter.com/gensightbio https://www.linkedin.com/company/gensight-biologics-sa/

B2B
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
tech for business
genetics
observatoire deeptech
neurology
biotech, medtech and e-health
eye diseases

Authorizing premium user...